Serologic biomarkers that are currently available for NSCLC are carcinoembryonic antigen (CEA) and serum cytokeratin 19 fragments (CYFRA 21-1) detailed below [43]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.